Abstract
1. The effect of various peptide antagonists on capsaicin-induced (250 micrograms per ear) ear inflammation has been examined. 2. Co-administration of the substance P (SP) antagonist [D-Pro2,D-Trp7,9]SP at 100 and 300 micrograms per ear with capsaicin markedly attenuated oedema, whereas a vasopressin antagonist was ineffective. 3. Using the same scheme, the mixed BK2 and BK1 bradykinin (BK) antagonist NPC 567 (D-Arg[Hyp3,D-Phe7]BK) did not inhibit oedema at 100 micrograms per ear, but did inhibit at a higher dose (300 micrograms). The BK1 antagonist [Leu8,desArg9]BK produced significant inhibition at both doses. 4. When BK was used to induce ear inflammation (30 micrograms per ear), the SP antagonist inhibited ear oedema. Both BK receptor subtype antagonists inhibited inflammation with the BK1 being more potent than the BK2 antagonist. 5. These results suggest that BK1 along with BK2 receptors are located on capsaicin-sensitive fibres, where they may modulate the degree of neurogenic inflammation.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bouthillier J., Deblois D., Marceau F. Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo. Br J Pharmacol. 1987 Oct;92(2):257–264. doi: 10.1111/j.1476-5381.1987.tb11319.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Butler J. M., Hammond B. R. The effects of sensory denervation on the responses of the rabbit eye to prostaglandin E1, bradykinin and substance P. Br J Pharmacol. 1980 Jul;69(3):495–502. doi: 10.1111/j.1476-5381.1980.tb07040.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geppetti P., Maggi C. A., Perretti F., Frilli S., Manzini S. Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart. Br J Pharmacol. 1988 Jun;94(2):288–290. doi: 10.1111/j.1476-5381.1988.tb11528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoover D. B. Effects of capsaicin on release of substance P-like immunoreactivity and physiological parameters in isolated perfused guinea-pig heart. Eur J Pharmacol. 1987 Sep 23;141(3):489–492. doi: 10.1016/0014-2999(87)90571-1. [DOI] [PubMed] [Google Scholar]
- Håkanson R., Beding B., Ekman R., Heilig M., Wahlestedt C., Sundler F. Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience. 1987 Jun;21(3):943–950. doi: 10.1016/0306-4522(87)90049-2. [DOI] [PubMed] [Google Scholar]
- Lembeck F., Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):175–183. doi: 10.1007/BF00500282. [DOI] [PubMed] [Google Scholar]
- Nagy J. I., Hunt S. P., Iversen L. L., Emson P. C. Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience. 1981;6(10):1923–1934. doi: 10.1016/0306-4522(81)90032-4. [DOI] [PubMed] [Google Scholar]
- Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980 Mar;32(1):1–46. [PubMed] [Google Scholar]
- Regoli D., Drapeau G., Rovero P., Dion S., D'Orléans-Juste P., Barabé J. The actions of kinin antagonists on B1 and B2 receptor systems. Eur J Pharmacol. 1986 Apr 9;123(1):61–65. doi: 10.1016/0014-2999(86)90687-4. [DOI] [PubMed] [Google Scholar]
- Shibata M., Ohkubo T., Takahashi H., Inoki R. Interaction of bradykinin with substance P on vascular permeability and pain response. Jpn J Pharmacol. 1986 Jul;41(3):427–429. doi: 10.1254/jjp.41.427. [DOI] [PubMed] [Google Scholar]